Holocene Advisors, LP Sage Therapeutics, Inc. Transaction History

Holocene Advisors, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$58.41 - $89.06 $191,409 - $291,849	-3,277 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$41.13 - $62.45 $71,812 - $109,037	-1,746 Reduced 34.76%	3,277 $200,000
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $130,346 - $216,742	5,023 New	5,023 $209,000
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $8.74 Million - $25.8 Million	-334,078 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $20.1 Million - $51.7 Million	334,078 New	334,078 $24.1 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $340M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.